Accure Therapeutics
Accure Therapeutics is a private pharma R&D engine at clinical stage in the CNS field.
Accure Therapeutics has raised €9.1M across 2 funding rounds from 3 investors, most recently a Grant round in Apr 2025. Based in Barcelona, Spain; founded 2020; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.1M
€9,058,922
Funding rounds
2
Investors
3
distinct backers
Active since
2020-05
latest 2025-04
Funding by year
EUR raised per yearAccure Therapeutics — funding by year — interactive chart.
Data table
| Accure Therapeutics — funding by year | |
|---|---|
| 2020 | €7.6M |
| 2025 | €1.5M |
Signals
High confidenceRaise-next likelihood21
base rate 45% for Grant
- ▼ Past typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 6y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-07 | Grant | €1.5M | Luxembourg National Research Fund (FNR),Michael J Fox Foundation for Parkinson’s Research (MJFF) | View deal → |
| 2020-05-29 | Series A | €7.6M | Alta Life Sciences | View deal → |
Investors
3Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData